Potential design rules and enzymatic synthesis of siRNAs
- PMID: 15017071
- DOI: 10.1385/1-59259-746-7:457
Potential design rules and enzymatic synthesis of siRNAs
Abstract
Small interfering RNAs (siRNAs) have emerged as a powerful technique for sequence-specific gene silencing in a wide variety of organisms. However, the base composition of the siRNA sequence is not the only determinant of efficacy. Intrinsic factors related to mRNA structures are likely to be crucial determinants for siRNA activity. Indeed, placing the recognition site of an active siRNA into a structured mRNA region has abrogated the siRNA activity. Therefore, a successful gene-targeting project may require the design of many distinct siRNAs at a high cost. Here, potential design rules, cost-effective strategies for producing siRNAs by T7 RNA polymerase, and expression cassettes for in vivo testing are described.
Similar articles
-
The impact of target site accessibility on the design of effective siRNAs.Nat Biotechnol. 2008 May;26(5):578-83. doi: 10.1038/nbt1404. Epub 2008 Apr 27. Nat Biotechnol. 2008. PMID: 18438400
-
[Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].Mol Biol (Mosk). 2006 Nov-Dec;40(6):1037-46. Mol Biol (Mosk). 2006. PMID: 17209432 Russian.
-
In silico selection of active siRNA.Drug Discov Today. 2007 Feb;12(3-4):139-48. doi: 10.1016/j.drudis.2006.11.015. Epub 2006 Dec 13. Drug Discov Today. 2007. PMID: 17275734 Review.
-
The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region.Biochem Biophys Res Commun. 2004 May 21;318(1):303-10. doi: 10.1016/j.bbrc.2004.04.027. Biochem Biophys Res Commun. 2004. PMID: 15110788
-
Solid-phase synthesis of siRNA oligonucleotides.Curr Opin Drug Discov Devel. 2008 Mar;11(2):203-16. Curr Opin Drug Discov Devel. 2008. PMID: 18283608 Review.
Cited by
-
Preclinical and clinical development of siRNA-based therapeutics.Adv Drug Deliv Rev. 2015 Jun 29;87:108-19. doi: 10.1016/j.addr.2015.01.007. Epub 2015 Feb 7. Adv Drug Deliv Rev. 2015. PMID: 25666164 Free PMC article. Review.
-
The infinite possibilities of RNA therapeutics.J Ind Microbiol Biotechnol. 2021 Dec 23;48(9-10):kuab063. doi: 10.1093/jimb/kuab063. J Ind Microbiol Biotechnol. 2021. PMID: 34463324 Free PMC article.
-
RNA interference in biology and disease.Blood. 2005 Aug 1;106(3):787-94. doi: 10.1182/blood-2004-12-4643. Epub 2005 Apr 12. Blood. 2005. PMID: 15827131 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources